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Background: Ivermectin and albendazole are used in annual mass drug administration (MDA) for the lymphatic
filariasis elimination programmes in African countries co-endemic for onchocerciasis, but have additional impact on
soil transmitted helminths and the ectoparasitic mite which causes scabies. Assessing these collateral impacts at
scale is difficult due to the insensitivity of available parasite detection techniques.
Methods: The numbers of cases diagnosed with intestinal helminths and scabies and who received prescriptions
for treatment were evaluated in 50 health centres in Zanzibar. Records were examined from 2000, prior to the
initiation of MDA to 2005, after six rounds of MDA for lymphatic filariasis had taken place.
Results: Health centre records showed a consistent decline in the number of cases of intestinal helminths and
scabies diagnosed by community health workers in Zanzibar and the number of prescriptions issued across five age
groups. A 90-98% decline in soil transmitted helminths and 68-98% decline in scabies infections were recorded.
Poisson regression models aggregated to both the island-level and district-level indicated that the decline was
statistically significant.
Conclusions: The described method of examining health centre records has the potential for use on a large scale,
despite limitations, as a rapid method to evaluate the impacts resulting from both lymphatic filariasis and
onchocerciasis MDA. This would result in a reduction in the need for parasitological evaluations to determine
prevalence and intensity.Background
In 1997, the World Health Assembly resolution
(WHA50.29) called on Member States to eliminate LF as
a public health problem by the year 2020 [1] and in
2000 the Global Programme to Eliminate Lymphatic Fil-
ariasis was initiated [2,3]. In Zanzibar, the Programme
for Eliminating Lymphatic Filariasis (PELF) administered
donated drugs, namely ivermectin (Mectizan) and alben-
dazole, annually to all eligible individuals for six con-
secutive years (2001–05), through a community-based
delivery system [4]. Following six rounds of MDA, in* Correspondence: david.molyneux@liv.ac.uk
†Equal contributors
2Centre for Neglected Tropical Diseases, Liverpool School of Tropical
Medicine, Liverpool L3 5QA, UK
Full list of author information is available at the end of the article
© 2012 Mohammed et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumwhich social and religious networks were used to achieve
high coverage, a marked reduction in both the microfi-
larial (mf) prevalence and intensity was seen in rural
and urban sentinel sites from Unguja, hence showing
the drug delivery strategy to be effective [4,5].
The eligibility criteria for individuals to receive treat-
ment during MDA are that individuals are over five
years of age (as determined by dose pole measured
height of 90 cms as a surrogate for age 5) and in good
health. Women who have recently given birth, pregnant
women, the elderly and extremely ill are not eligible to
receive medication.
MDA is effective at reducing prevalence and microfi-
larial load of Wuchereria bancrofti infection [2,3,5,6],
but additional benefits accrue because of the impact of
albendazole and ivermectin on other helminths andntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Ascaris lumbricoides (roundworm), hookworm and to a
lesser extent on Trichuris trichiura (whipworm) (collect-
ively the soil transmitted helminths, [STH]), and scabies
respectively [7,8]. Studies by Knopp et al. [9] successfully
demonstrated a decrease in prevalence of more than
95% of STHs following the delivery of benzimidazoles
(albendazole and mebendazole) alone within the school
health strategy system in Unguja island, Zanzibar but
not on Pemba [9].
Ivermectin monotherapy reduces scabies prevalence
after a single treatment, with almost complete disappear-
ance of infection after 2 or more treatments [10]. For ex-
ample, in the Solomon Islands the prevalence of scabies
fell from a mean of 25% to 1% and scabies associated
sores fell from 40% to 21% [7] following the administra-
tion of ivermectin. Ivermectin is used in both onchocer-
ciasis and LF programmes in Africa [2].
The aim of this study was to test a new methodology
for assessing the impact of MDA for lymphatic filariasis
on the reduction in the number of cases of STH and
scabies retrospectively by checking health centre records
where MDA distribution had taken place. The approach
adopted can be regarded as a “rapid assessment” ap-
proach. In resource poor settings it is not possible to
routinely undertake large numbers of stool and skin
examinations due to both cost and limited human
resources. Faecal examination, the “gold standard” for
parasitological diagnosis, is a relatively insensitive
method, and given the impact of MDA for LF on the in-
tensity of STH infections, that inherent lack of sensitivity
will be compounded following several rounds of MDA.
The use of rapid approaches as opposed to gold standard
diagnoses, which are often invasive, is a diagnostic ap-
proach widely used to determine geographic distribution
as well as impact of MDA on neglected diseases targeted
for preventive chemotherapy [11,12].
Methods
To determine the impact of MDA for LF on STH and
scabies, 50 primary health care units (PHCU) in the ten
districts of Zanzibar were chosen. Five PHCUs were
selected at random in each district and the record regis-
ters were used to obtain data of registered cases of STH
and scabies during a six year period (2000–2005). Thirty
PHCUs were on Unguja Island and 20 on Pemba. The
information collected in 2000 formed the baseline data
for the number of cases identified prior to the initiation
of the MDA programme.
Permission to access these records was obtained from
the Ministry of Health and Social Welfare, Zanzibar.
Data acquired from patient registers included the name,
age, sex, complaint and treatment of individuals who vis-
ited the PHCU. The register for each year and healthfacility was systematically examined by two data extrac-
tors to reduce the potential for human error resulting
from reading handwritten patient registers completed by
health staff. The data extractors were also provided with
specific guidelines on what could be considered reliable
data. Drugs had been provided to all individuals attend-
ing PHCUs, either at the health facility itself or from the
local pharmacies if a prescription was required. Stool
examinations were not conducted due to the limited
sensitivity of the Kato-Katz method for determining
prevalence and intensity particularly after 6 years of
MDA with high coverage [5].
Case-level analysis
Data from five age groups was obtained: birth-5 years,
6–10 years, 11–15 years, 16–20 years and over 20 year
olds. Children in the birth-5 years age group, although
ineligible to receive medication through the LF MDA
programme, were included as they represented a surro-
gate baseline indicator for the prevalence of STH in un-
treated children.
To calculate the number of reported and treated STH
cases, health records of patients who indicated abdom-
inal pain, passing of worms, and who were recommended
to be treated with albendazole were enumerated. Other
conditions that had been treated with mebendazole or
albendazole were also included.
Scabies cases were defined as patients presenting with
a skin condition characteristic of scabies skin disease
and rashes, and who were prescribed with the standard
treatment Scabex (benzyl benzoate).
Island-level analysis
A Poisson regression model was fitted to data from each
of the islands independently for both STH and scabies,
with the outcome variable being the number of cases of
each of the conditions. Both year and age group were
considered as explanatory variables in the regression
models to determine whether there was a significant de-
crease in recorded cases over time, and if the number of
cases varied significantly between age groups. The birth-5
age group was used as the reference age group.
District-level analysis
Scatterplots of the number of cases of the disease at the
district-level each year suggested that the number of
cases in some districts were intrinsically higher or lower
than others. As these between-district differences cannot
be fully quantified, a Poisson random effects model
with a random intercept by district was fitted to the
district-level case data. As with the model at the island-
level, year and age group were included in the model
as explanatory variables. Differences in district-level
Table 2 Reported cases of scabies in Unguja
Year 0–5 yrs 6–10 yrs 11–15 yrs 16–20 yrs >20 yrs
2000 1273 1281 1282 973 703
2001 930 995 889 718 670
2002 563 297 197 131 90
2003 376 201 132 72 50
2004 190 129 79 47 29
2005 122 61 36 14 9
Legend: Cases recorded in PHCUs between 2000 and 2005.
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log-transformed population estimates from the 2002 na-
tional census as an offset (http://www.nbs.go.tz/takwimu/
references/2002popcensus.pdf ). A likelihood ratio test
was undertaken in order to assess the significance of
the random effects.
Ethical approval of the study was given by the Ministry
of Health and Social Welfare, Zanzibar and the Ethical
Committee of the Liverpool School of Tropical Medicine
as part of a PhD study by KM.
Results
Case level analysis
Soil transmitted helminths
The results indicated that over a period of five years
there was a clear decline in the number STH cases
reported at health clinics on Unguja and Pemba islands
in Zanzibar (Tables 1, 2 and 3). On Unguja, the largest
decrease (98.17%) in reported cases was seen in the over
20 years age group. Similar trends in number of reported
cases were also seen in the 11–15 year age group
(97.14%), the 6–10 year group (94.44%) and the 16–20
year age group (97.06%) (Figure 1). The smallest de-
crease (89.63%) was in the birth-5 year age group. The
highest decline was in Pemba, in the 11–15 year age
group (97.44%). Other decreases in numbers of reported
cases included; 16–29 years (97.38%), >20 years
(97.33%), 6–10 years (96.86%). The birth-5 years age
group demonstrated the lowest decline (92.97%) in num-
ber of reported cases (Figures 1 and 2).
Scabies
The records of scabies declined dramatically over the
period 2000–2005 with most significant decreases
(98.72%) being seen on Unguja (in the over 20 year age
group) (Figure 2). Other age groups on Unguja also
demonstrated consistently high reductions in recorded
cases; 98.56% (16–20 years), 97.19% (11–15 years),
95.24% (6–10 years) and 90.42% (birth-5 years). In
Pemba, decreases in scabies cases reported were in age
groups: 11–15 years (89.47%), 16–20 years (82.93%),
6–10 years (81.32%) and over 20 years (76.92%). TheTable 1 Reported cases of soil-transmitted helminths in
Unguja
Year 0–5 yrs 6–10 yrs 11–15 yrs 16–20 yrs >20 yrs
2000 1881 1385 1330 715 547
2001 1251 801 948 511 299
2002 650 445 252 172 101
2003 455 259 171 122 66
2004 388 153 108 49 33
2005 195 77 38 21 10
Legend: Cases recorded in PHCUs between 2000 and 2005.birth-5 years group showed a 68.46% decrease (Figures 1
and 3) and (Table 4).
Island-level analysis
Table 5 presents the estimated coefficients and their
associated 95% confidence intervals on the log-scale for
each of the four Poisson regression models fitted to the
island-level data. Each of these models showed there was
a statistically significant decrease in the number of cases
over time. The decrease in cases over time was greater
in Pemba than Unguja, whilst the effects of time appear
to be greater in STH cases in comparison to scabies.
District-level analysis
Figure 4 presents scatter plots of incidence of both STH
and scabies on the log-scale at the district-level between
2000–2005. These plots show that the overall trend of
cases decreases over the period of the MDA. Further,
while there was a large amount of variability between
the districts in a given year, the trend is broadly similar
across all districts. These observations support the fitting
of a Poisson random effects model with a random inter-
cept. Table 6 presents the estimated coefficients and
their associated 95% confidence intervals on the log-
scale for the two Poisson random effects models fitted
to the district-level data. The results obtained for the
island-level models showed that there was a statistically
significant decrease in the number of cases over time. In
contrast to the island-level models, the effect of time
was stronger in the scabies model in comparison to the
STH model, although the difference was small (−0.5991Table 3 Reported cases of soil-transmitted helminths in
Pemba
Year 0–5 yrs 6–10 yrs 11–15 yrs 16–20 yrs >20 yrs
2000 1539 1212 938 496 338
2001 996 598 631 338 159
2002 476 206 116 81 59
2003 332 113 78 46 33
2004 200 70 44 28 17
2005 111 38 24 13 9
Legend: Cases recorded in PHCUs between 2000 and 2005.
Figure 1 Soil-transmitted helminths and scabies in Unguja and Pemba 2000–2005. Number of reported cases of soil-transmitted helminths
and scabies in public health units (PHC) on Unguja and Pemba, Zanzibar.
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model). These results also demonstrated that there was
a statistically significant relationship between the num-
ber of cases and age group in both the STH and scabies
models, with the risk of infection being greatest in the
birth-5 year age group, following which the risk
decreases with age. This relationship was more pro-
nounced for STH. The random effects term in both of
the models was significant (p<0.0001) indicating that
there were between-district differences in the overalllevel of both diseases after accounting for differences in
population sizes.
Discussion
A decrease in the number of STH and scabies cases
diagnosed by health centre staff from 50 health facilities
in Unguja and Pemba after the LF elimination
programme had distributed ivermectin and albendazole
between 2000–2005 was found in all age groups. We re-
port these results conscious that the methodology we
Figure 2 Soil transmitted helminths in Pemba and Unguja (2000–2005). Number of reported cases of scabies in Pemba and Unguja combined.
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that the method merits further investigation as MDA
programmes upscale towards the milestones set by
WHO with regards to achieving the maximum coverage
of preventive chemotherapy by MDA for onchocerciasis,
lymphatic filariasis, schistosomiasis and soil transmit-
ted helminths (http://www.who.int/neglected_diseases/
resources/en/index.html). Specifically, it is envisaged
that over one billion annual treatments are required if
targets for control or elimination of these diseases are
to be met.
The limitations that can be identified reflect the settings
of a busy health centre environment, where diagnosis is
made predominantly on history and symptomatology. InFigure 3 Scabies in Pemba and Unguja (2000–2005). Number of report
combined.the case of helminth infections, only severe or moderate
cases which give rise to symptoms will present, whilst the
presentation of those with low grade infection is less
likely. Diagnosis of scabies is more reliable due to charac-
teristic skin lesions presented. Despite such differences in
infection status and reliability of diagnostic methods used
in health centres, the trends we describe for both STH
and scabies after prolonged ivermectin and albendazole
distribution within the community are similar. Given the
unspecific nature of clinical presentations of STH,
consistency in recording STH in health centre records is
important. Health staff diagnose on the basis of experi-
ence, however, as the same staff tend to be in post over
many years we would argue that the data obtained can beed cases of soil transmitted helminths in Pemba and Unguja
Table 4 Reported cases of scabies in Pemba
0–5 yrs 6–10 yrs 11–15 yrs 16–20 yrs >20 yrs
2000 241 182 209 41 26
2001 472 389 318 239 109
2002 317 135 90 60 46
2003 214 76 47 30 21
2004 119 47 32 18 12
2005 76 34 22 7 6
Legend: Cases recorded in PHCUs between 2000 and 2005.
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Whilst low grade and hence less intense infections would
not present to clinics yet still benefit from the anthel-
minthic benefits of MDA, the results can be interpreted
as a consistent decline in the numbers of people with
moderate to severe symptoms associated with STH.
Despite these limitations we believe the consistent decline
in two groups of infections determined using this rapid
methodology allows retrospective analysis of data. This
would not be possible using classical approaches. The
trends of decline were observed in two different islands,
in all age groups and in 50 health centres for conditions
which are biologically different in terms of transmission
yet are affected by the drugs deployed in MDA, support-
ing the further exploration of the methodology in a more
controlled setting. Importantly, the trends in scabies can
be viewed as a control for the STH observations as
scabies is more easily diagnosed by health staff and the
scabies results mirror those of STH in both the districts
and the islands. We did not record the total number of
individuals who presented at these clinics during the
study period.
The results are also consistent with the reported high
MDA coverage [5] during the period of 2000–2005. The
Global LF programme and onchocerciasis programmes
are together administering MDA in around 60 countries,
and over 600 million people each year are benefitting
from these drugs, which have broad anthelminthic im-
pact [3,8]. There is therefore a need to evaluate theTable 5 Effect size and associated confidence intervals obtain
STH and scabies data from Unguja and Pemba
Model Year Age
0-5
Age 6-10
Coefficient 95% CI Coefficient 95% CI Coe
STH
Unguja
−0.5641 (−0.5769,
-0.5513)
- −0.4349 (−0.4801,
-0.3900)
−0.5
STH
Pemba
−0.6662 (−0.6829,
-0.6496)
- −0.4907 (−0.5434,
-0.4382)
−0.6
Scabies
Unguja
−0.3508 (−0.3720,
-0.3297)
- −0.5113 (−0.5960,
-0.4272)
−0.6
Scabies
Pemba
−0.6388 (−0.6529,
-0.6249)
- −0.1530 (−0.2021,
-0.1039)
−0.2broader synergistic impact on both STH and scabies of
MDAs and the approach we describe merits consider-
ation for the reasons we articulate below.
We suggest that the use of the gold standard approach
the Kato-Katz test, as well as other more sensitive con-
centration techniques, would be both impractical and
costly to undertake at scale as they require extensive
stool collection and laboratory diagnosis. Furthermore
they cannot be carried out retrospectively. Indeed, des-
pite the extensive distribution of anthelminthics as part
of LF and onchocerciasis programmes, we are not aware
of any pre-MDA STH or scabies baseline data being
available. While it may be appropriate to evaluate the
outcomes using classical methods in limited settings, to
contemplate, the use of such methods at scale when
there will have been a significant reduction in the sensi-
tivity of the test because of wide scale MDA would seem
inappropriate.
National guidelines stipulate that only children of 5
years old (90 cm in height as a surrogate) and above
should receive the medication for lymphatic filariasis,
hence the youngest age group (birth-5 years) would not
be treated. However, an observed decline in STH and
scabies for this group after the initiation of MDA sug-
gested that the treatment of the older age groups
impacted on the birth-5 year old group also. This may
also have been attributed to the national helminth
programme, which targeted the younger age groups dur-
ing the same period [8] although this confounder would
not be present in the older age groups nor would influ-
ence the scabies results.
STH has been recognised as a problem in Zanzibar
since surveys revealed prevalence in school aged chil-
dren to be 72% for Ascaris lumbricoides, 94% for Tri-
churis trichiura and 95% for hookworm in Pemba [13].
This study indicated a marked decrease in reported STH
diagnosis, with this reduction likely to be in those with
moderate or severe infections of hookworm and Ascaris.
Studies in Haiti and Sri Lanka indicated that significant
decreases in STH were observed [14,15] following theed from fitting a Poisson regression model to aggregated
Age 11-15 Age 16-20 Age > 20
fficient 95% CI Coefficient 95% CI Coefficient 95% CI
265 (−0.5729,
-0.4803)
−1.1090 (−1.1660,
-1.0526)
−1.5180 (−1.5854,
-1.4522)
910 (−0.7473,
-0.6350)
−1.2938 (−1.3642,
-1.2244)
−1.7820 (−1.8683,
-1.6974)
952 (−0.7853,
-0.6061)
−1.2928 (−1.4054,
-1.1826)
−1.8781 (−2.0225,
-1.7386)
783 (−0.3291,
-0.2275)
−0.5691 (−0.6248,
-0.5138)
−0.8006 (−0.8608,
-0.7409)
Figure 4 Number of STH and scabies cases per 10,000 people on the log-scale at the district-level in Zanzibar over the period 2000–
2005. Lines connect data from the same district.
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ness of albendazole treatment.
In our study the total number of scabies cases identi-
fied was considerably lower than during the period prior
to the initiation of MDA for LF. Studies by Bockarie
et al. [16] showed the effectiveness of ivermectin on sca-
bies, particularly in areas of high prevalence, where a
disappearance of scabies due to the impact of ivermectin
was demonstrated [16]. Scabies is diagnosed at the pri-
mary health care level when patients present with itchy
papules and characteristic rash [17], although definitive
techniques including dermoscopy, skin scraping and the
adhesive tape test give a precise diagnosis [17]. Although
mass screening and treatment of individuals affected by
scabies would lead to a significant decrease in scabies
prevalence, Gilmore [18] identified that it would it be
difficult to sustain the implementation of such protocols
over extended periods. Ivermectin is not an indicated
drug for scabies despite its efficacy [7,10] and the bene-
fits of ivermectin for scabies can only be assessed where
it is used in LF and onchocerciasis programmes.
Speich et al. [19] estimated the cost of a Kato-Katz
test as 1.73 US$ on Zanzibar, a figure which contrasts
with the annual costs of LF MDA distribution in Tan-
zania of 0.26-0.54 US$ per person [20]. We consider
that it is not feasible to initiate large scale stool exam-
ination using techniques which are costly, time consumingTable 6 Effect size and associated confidence intervals obtain
random intercept by district to the district-level STH and scab
Model Year Age
0-5
Age 6-10
Coefficient 95% CI Coefficient 95% CI Coeff
STH −0.5991 (−0.6036,
-0.5947)
- −0.4464 (−0.4615,
-0.4313)
−0.57
Scabies −0.6421 (−0.6471,
-0.6371)
- −0.1949 (−0.2121,
-0.1776)
−0.34
Data from Unguja and Pemba are combined.and insensitive for the assessment of the impact of MDA
for LF and onchocerciasis. The approach we suggest,
which despite its limitations, appears to provide consist-
ent results, could be applied retrospectively and does not
require the deployment of technical staff or the collec-
tion, transport and storage of stool samples.
Conclusions
We propose a rapid methodology based on health
records to assess the impact of MDA for lymphatic filar-
iasis on STH and scabies. This approach would not re-
quire the extensive parasitological examination of stools,
which is costly and not applicable at scale. The results
suggest that distribution of albendazole and ivermectin
has an impact on the number of reported cases of mod-
erate to severe STH infections and scabies when health
centre records are used as a surrogate for “gold stand-
ard” parasitological diagnosis. Further studies are
required to validate the methodology to assess the im-
pact of ivermectin and albendazole on the prevalence of
STH and scabies, but we consider that the use of his-
toric records could provide a much needed rapid assess-
ment alternative to standard parasitological methods
where sensitivity will be compromised by MDA. The
method could be used retrospectively where MDA for
preventive chemotherapy has already been undertaken,
as well as in areas yet to upscale.ed from fitting a Poisson random effects model with a
ies data
Age 11-15 Age 16-20 Age > 20
icient 95% CI Coefficient 95% CI Coefficient 95% CI
18 (−0.5875,
-0.5562)
−1.1604 (−1.1797,
-1.1411)
−1.5924 (−1.6153,
-1.5695)
05 (−0.3585,
-0.3225)
−0.6473 (−0.6671,
-0.6275)
−0.9375 (−0.9594,
-0.9157)
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